Zimbabwe has turned down a substantial US health deal valued at $367m (272 million pounds) spanning five years due to the United States' insistence on sensitive information.
This rejection became public after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "skewed".
An official representative later stated that the United States was demanding access to genetic material for scientific study and commercial purposes but was not willing to guarantee the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further talks to reach a deal agreeable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision follows a similar situation in Kenya, where a high court blocked a similar health funding agreement after concerns were raised about the security of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.
According to reports, 16 African countries have to date agreed to similar health pacts, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our people should a future pandemic arise."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This framework is designed to guarantee that when a nation provides its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.
"We are open to ongoing dialogue with our US partners on how future collaboration might be structured in a manner that respects the sovereignty and interests of each country."
Health Experts Response
A leading public health body expressed it acknowledged the government's concerns, but suggested that negotiations must proceed given that a large portion of the country's Aids initiatives depended on foreign aid.
"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The situation emphasises the ongoing debate between accepting much-needed international aid and safeguarding a country's data in an ever more interconnected world.